INCYTE CORPORATION Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31)
INCYTE CORPORATION (INCY) reported Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) of -$130.00 thousand for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-10-27.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease · last filed 2011-10-27
- INCYTE CORPORATION other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-09-30 was -$130.00K, a 197.01% decline year-over-year.
- INCYTE CORPORATION other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-06-30 was -$138.00K, a 123.08% decline year-over-year.
- INCYTE CORPORATION other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2011-03-31 was $103.00K, a 79.02% decline year-over-year.
- INCYTE CORPORATION other comprehensive income (loss), net of tax (deprecated 2012-01-31) for the quarter ending 2010-09-30 was $134.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Net of Tax (Deprecated 2012-01-31) 9 month |
|---|---|---|---|
| 2011-09-30 | -$130.00K 10-Q · filed 2011-10-27 | -$268.00K derived: sum of 2 quarters · filed 2011-10-27 | -$165.00K 10-Q · filed 2011-10-27 |
| 2011-06-30 | -$138.00K 10-Q · filed 2011-07-28 | -$35.00K 10-Q · filed 2011-07-28 | |
| 2011-03-31 | $103.00K 10-Q · filed 2011-05-03 | ||
| 2010-09-30 | $134.00K 10-Q · filed 2011-10-27 | $732.00K derived: sum of 2 quarters · filed 2011-10-27 | $1.22M 10-Q · filed 2011-10-27 |
| 2010-06-30 | $598.00K 10-Q · filed 2011-07-28 | $1.09M 10-Q · filed 2011-07-28 | |
| 2010-03-31 | $491.00K 10-Q · filed 2011-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |